Peter Ruf

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• Inserm10.4%
• Humboldt-Universität zu Berlin9.4%
• Roche (Switzerland)7.9%
• Novartis (Switzerland)7.5%
• Ludwig-Maximilians-Universität München7.3%
• Pfizer (United States)6.5%
• Other51.1%

Fields

• Medicine81.4%
• Biochemistry, Genetics and Molecular Biology9.3%
• Immunology and Microbiology6.8%
• Chemistry1.4%
• Computer Science0.4%
• Engineering0.4%
• Other0.4%

Topics

• Monoclonal and Polyclonal Antibodies Research24.5%
• CAR-T cell therapy research14.9%
• Immunotherapy and Immune Responses10%
• Cancer Cells and Metastasis6.9%
• Renin-Angiotensin System Studies6.5%
• Glycosylation and Glycoproteins Research6.1%
• Other31%